Drug discovery

Non-profit alliance aims to advance treatments for rare diseases

The BioPontis Alliance hopes its new model for bringing patients’ insights and industry expertise to bear in preclinical research will reduce risk and promote development of rare disease therapies. The Alliance has funding from a Belgian charity for its first project
14 Jan 2016

LERU calls for equal partnership in IMI 2

The League of European Research Universities has once again hit out at IP rules and funding levels in the EU’s Innovative Medicines Initiative, saying academics will be discouraged from taking part in the €2B collaborative research programme
12 Jun 2013